Financials
Income statement
| Fiscal date | Jul 2025 | Apr 2025 | Jan 2025 | Oct 2024 |
|---|---|---|---|---|
| Total reported revenue | 39.8B | 37.5B | 33.5B | 29.9B |
| Cost of revenue | 11.0B | 14.8B | 9.0B | 7.6B |
| Gross profit | 28.8B | 22.7B | 24.5B | 22.3B |
| Operating expense | ||||
| Research & development | 3.7B | 3.4B | 3.2B | 2.9B |
| Selling general and admin | 955.3M | 886.3M | 830.1M | 763.7M |
| Other operating expenses | — | — | — | — |
| Operating income | 24.2B | 18.4B | 20.5B | 18.6B |
| Non operating interest income | ||||
| Income | 504.0M | 438.5M | 435.1M | 401.9M |
| Expense | 52.8M | 53.6M | 51.9M | 51.9M |
| Other income expense | 1.9B | -153.3M | 624.1M | 30.7M |
| Pretax income | 26.6B | 18.7B | 21.5B | 19.0B |
| Tax provision | 4.1B | 2.7B | 2.7B | 2.6B |
| Net income | 22.5B | 16.0B | 18.8B | 16.4B |
| Basic EPS | 1.1 | 0.8 | 0.9 | 0.8 |
| Diluted EPS | 1.1 | 0.8 | 0.9 | 0.8 |
| Basic average shares | 20.7B | 20.8B | 20.8B | 20.9B |
| Diluted average shares | 20.9B | 21.0B | 21.0B | 21.1B |
| EBITDA | 27.2B | 19.2B | 22.0B | 19.5B |
| Net income from continuing op. | 22.5B | 16.0B | 18.8B | 16.4B |
| Minority interests | — | — | — | — |
| Preferred stock dividends | — | — | — | — |